Carnegie Investment Counsel - ANAVEX LIFE SCIENCES CORP ownership

ANAVEX LIFE SCIENCES CORP's ticker is AVXL and the CUSIP is 032797300. A total of 144 filers reported holding ANAVEX LIFE SCIENCES CORP in Q2 2024. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Carnegie Investment Counsel ownership history of ANAVEX LIFE SCIENCES CORP
ValueSharesWeighting
Q2 2024$309,465
-17.1%
73,3330.0%0.01%
-16.7%
Q1 2024$373,265
-45.6%
73,333
-0.4%
0.01%
-50.0%
Q4 2023$685,775
+55.3%
73,660
+9.3%
0.02%
+41.2%
Q3 2023$441,536
-20.2%
67,410
-1.0%
0.02%
-15.0%
Q2 2023$553,328
+47.8%
68,060
+55.8%
0.02%
+33.3%
Q1 2023$374,295
+115.6%
43,675
+132.9%
0.02%
+114.3%
Q4 2022$173,62518,7500.01%
Other shareholders
ANAVEX LIFE SCIENCES CORP shareholders Q2 2024
NameSharesValueWeighting ↓
AllSquare Wealth Management LLC 51,966$219,2970.13%
GSA CAPITAL PARTNERS LLP 220,860$9320.06%
SAXON INTERESTS, INC. 26,699$112,6700.05%
Hikari Power Ltd 85,585$3610.03%
Sculptor Capital LP 371,400$1,567,3080.03%
Sculptor Capital LP 370,400$1,563,0880.03%
Y-Intercept (Hong Kong) Ltd 94,578$399,1190.02%
Opus Capital Group, LLC 32,700$1380.02%
Hayek Kallen Investment Management 11,863$500.02%
Geneos Wealth Management Inc. 89,725$378,6400.02%
View complete list of ANAVEX LIFE SCIENCES CORP shareholders